Neuroendocrine Tumor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ABUS | B | Arbutus Biopharma Corporation | 1.20 | |
CRNX | C | Crinetics Pharmaceuticals, Inc. | -2.12 | |
AQST | D | Aquestive Therapeutics, Inc. | -1.03 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MNTL | D | Tema Neuroscience and Mental Health ETF | 3.2 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 2.54 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 2.15 | |
XBI | C | SPDR S&P Biotech ETF | 1.26 | |
GERM | C | ETFMG Treatments Testing and Advancements ETF | 1.21 |
Compare ETFs
Related Industries:
Biotechnology
- Neuroendocrine Tumor
A neuroendocrine tumor (NET) is a type of cancer that develops from cells of the neuroendocrine system. This system is made up of cells that release hormones in response to signals from the nervous system. Neuroendocrine tumors can occur anywhere in the body and can be benign (non-cancerous) or malignant (cancerous). Symptoms of NETs vary depending on the location and type of tumor, but may include abdominal pain, diarrhea, weight loss, and fatigue. Treatment options may include surgery, chemotherapy, radiation, and targeted therapy.
Recent Comments
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
From the Blog
Featured Articles